Publication: Signs and Symptoms of Dry Eye in Keratoconus Patients: A Pilot Study
Loading...
Official URL
Full text at PDC
Publication Date
2015-11
Authors
Recchioni, Alberto
Alejandre Alba, Nicolás
Crooke, Almudena
Jiménez Alfaro-Morote, Ignacio
Pintor, Jesús
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Taylor & Francis
Citations
Exportar
Abstract
Purpose: To compare signs and symptoms of dry eye in keratoconus (KC) patients versus healthy subjects.
Methods: A total of 15 KC patients (KC group, n = 15 eyes) and 16 healthy subjects (control group, 16 eyes) were enrolled in this study. The Schirmer I test with no anesthetic, tear break-up time (TBUT), corneal staining characteristics, and ocular surface disease index (OSDI) scores were evaluated for both groups. Impression cytology, combined with/scanning laser confocal microscopy (LCM), was performed to evaluate goblet cell density, mucin cloud height (MCH), and goblet cell layer thickness (CLT). Finally, tear concentrations of di-adenosine tetraphosphate (Ap4A) were assessed. Results were statistically analyzed using Shapiro–Wilk and non-parametric Wilcoxon rank sum tests. Statistical significance was set at p < 0.05.
Results: KC patients had lower tear volumes and greater corneal staining than did healthy subjects (p < 0.05). OSDI scores were 44.96 ± 8.65 and 17.78 ± 6.50 for the KC and control groups, respectively (p < 0.05). We found no statistically significant differences in TBUT between groups. Impression cytology revealed lower goblet cell densities in KC group patients versus control group subjects (84.88 ± 32.98 and 128.88 ± 50.60 cells/mm,2 respectively, p < 0.05). There was a statistically significant reduction in MCH and CLT in KC group patients compared with control group subjects. Ap4A tear concentrations were higher in KC group patients than in control group subjects (2.56 ± 1.10 and 0.15 ± 0.12 µM, respectively, p < 0.05).
Conclusions: The parameters evaluated in this study indicate that KC patients suffer greater symptoms of dry eye and greater tear instability, primarily due to the decreased mucin production in their tears, than do healthy patients with no KC.
Description
Received 13 December 2013; revised 4 November 2014; accepted 9 November 2014; published online 9 December 2014
UCM subjects
Unesco subjects
Keywords
Citation
1. Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998;42: 297–319.
2. Kymes SM, Walline JJ, Zadnik K, Gordon MO, Collaborative Longitudinal Evaluation of Keratoconus Study Group. Quality of life in keratoconus. Am J Ophthalmol 2004;138:527–535.
3. Dogru M, Karakaya H, Ozcetin H, Erturk H, Yucel A, Ozmen A, et al. Tear function and ocular surface changes in keratoconus. Ophthalmology 2003;110:1110–1118.
4. Kymes SM, Walline JJ, Zadnik K, Sterling J, Gordon MO, Collaborative Longitudinal Evaluation of Keratoconus Study Group. Changes in the quality-of-life of people with keratoconus. Am J Ophthalmol 2008;145: 611–617.
5. Rabinowitz YS, Nesburn AB, McDonnell PJ. Videokeratography of the fellow eye in unilateral keratoconus. Ophthalmology 1993;100:181–186.
6. Choi JA, Kim MS. Progression of keratoconus by longitudinal assessment with corneal topography. Invest Ophthalmol Vis Sci 2012;53:927–935.
7. Hashemi H, Beiranvand A, Khabazkhoob M, Asgari S, Emamian MH, Shariati M, et al. Prevalence of keratoconus in a population-based study in Shahroud. Cornea 2013;32: 1441–1445.
8. Xu L,Wang YX, Guo Y, You QS, Jonas JB, Beijing Eye Study Group. Prevalence and associations of steep cornea/keratoconus in Greater Beijing. The Beijing Eye Study. PLoS One 2012;7:e39313.
9. Millodot M, Shneor E, Albou S, Atlani E, Gordon-Shaag A. Prevalence and associated factors of keratoconus in Jerusalem: a cross-sectional study. Ophthalmic Epidemiol 2011;18:91–97.
10. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol 1986;101:267–273.
11. Nielsen K, Hjortdal J, Pihlmann M, Corydon TJ. Update on the keratoconus genetics. Acta Ophthalmol 2013;91: 106–113.
12. Nemet AY, Vinker S, Bahar I, Kaiserman I. The association of keratoconus with immune disorders. Cornea 2010;29: 1261–1264.
13. McMonnies CW. Abnormal rubbing and keratectasia. Eye Contact Lens 2007;33:265–271.
14. McMonnies CW, Boneham GC. Keratoconus, allergy, itch, eye-rubbing and hand-dominance. Clin Exp Optom 2003; 86:376–384.
15. Lema I, Brea D, Rodriguez-Gonzalez R, Diez-Feijoo E, Sobrino T. Proteomic analysis of the tear film in patients with keratoconus. Mol Vis 2010;16:2055–2061.
16. Lema I, Sobrino T, Duran JA, Brea D, Diez-Feijoo E. Subclinical keratoconus and inflammatory molecules from tears. Br J Ophthalmol 2009;93:820–824.
17. Lema I, Duran JA, Ruiz C, Diez-Feijoo E, Acera A, Merayo J. Inflammatory response to contact lenses in patients with keratoconus compared with myopic subjects. Cornea 2008; 27:758–763.
18. Murube J, Rivas L. Impression cytology on conjunctiva and cornea in dry eye patients establishes a correlation between squamous metaplasia and dry eye clinical severity. Eur J Ophthalmol 2003;13:115–127.
19. Rivas L, Oroza MA, Perez-Esteban A, Murube-del-Castillo J. Morphological changes in ocular surface in dry eyes and other disorders by impression cytology. Graefes Arch Clin Exp Ophthalmol 992;230:329–334.
20. Peral A, Pintor J. Ocular mucin visualization by confocal laser scanning microscopy. Cornea 2008;27: 395–401.
21. Peral A, Carracedo G, Acosta MC, Gallar J, Pintor J. Increased levels of diadenosine polyphosphates in dry eye. Invest Ophthalmol Vis Sci 2006;47:4053–4058.
22. Carracedo G, Peral A, Pintor J. Diadenosine polyphosphates in tears of Sjogren syndrome patients. Invest Ophthalmol Vis Sci 2010;51:5452–5459.
23. Tognoni G. The new Helsinki declaration. Assist Inferm Ric 2009;28:49–51.
24. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969;82:10–14.
25. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:108–152.
26. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:75–92.
27. Lazarowski ER, Watt WC, Stutts MJ, Boucher RC, Harden TK. Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br J Pharmacol 1995;116:1619–1627.
28. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118:615–621.
29. Simpson TL, Situ P, Jones LW, Fonn D. Dry eye symptoms assessed by four questionnaires. Optom Vis Sci 2008;85: 692–699.
30. Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 2010; 128:94–101.
31. McMahon TT, Szczotka-Flynn L, Barr JT, Anderson RJ, Slaughter ME, Lass JH, et al. A new method for grading the severity of keratoconus: the Keratoconus Severity Score (KSS). Cornea 2006;25:794–800.
32. Balasubramanian SA, Pye DC, Willcox MD. Effects of eye rubbing on the levels of protease, protease activity and cytokines in tears: relevance in keratoconus. Clin Exp Optom 2013;96:214–218.
33. Balasubramanian SA, Mohan S, Pye DC, Willcox MD. Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus. Acta Ophthalmol 2012; 90:e303–309.
34. Fodor M, Kolozsvari BL, Petrovski G, Kettesy BA, Gogolak P, Rajnavolgyi E, et al. Effect of contact lens wear on the release of tear mediators in keratoconus. Eye Contact Lens 2013;39:147–152.
35. Zemova E, Eppig T, Seitz B, Toropygin S, Arnold S, Langenbucher A, et al. Interaction between topographic/ tomographic parameters and dry eye disease in keratoconus patients. Curr Eye Res 2013.
36. Machado LM, Castro RS, Fontes BM. Staining patterns in dry eye syndrome: rose bengal versus lissamine green. Cornea 2009;28:732–734.
37. Cho KJ, Mok JW, Choi MY, Kim JY, Joo CK. Changes in corneal sensation and ocular surface in patients with asymmetrical keratoconus. Cornea 2013;32:205–210.
38. Acar BT, Vural ET, Acar S. Effects of contact lenses on the ocular surface in patients with keratoconus: piggyback versus ClearKone hybrid lenses. Eye Contact Lens 2012;38: 43–48.
39. Carracedo G, Guzman-Aranguez A, Loma P, Pintor J. Diadenosine polyphosphates release by human corneal epithelium. Exp Eye Res 2013;113:156–161.
40. Pintor J, Bautista A, Carracedo G, Peral A. UTP and diadenosine tetraphosphate accelerate wound healing in the rabbit cornea. Ophthalmic Physiol Opt 2004;24:186–193.
41. Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol 2008;146:350–356.
42. Gonzalez-Meijome JM, Parafita MA, Yebra-Pimentel E, Almeida JB. Symptoms in a population of contact lens and noncontact lens wearers under different environmental conditions. Optom Vis Sci 2007;84:296–302.
43. Guillon M, Maissa C. Dry eye symptomatology of soft contact lens wearers and nonwearers. Optom Vis Sci 2005; 82:829–834.
44. Doughty MJ. Contact lens wear and the goblet cells of the human conjunctiva – a review. Cont Lens Anterior Eye 2011;34:157–163.
45. Tyagi G, Alonso-Caneiro D, Collins M, Read S. Tear film surface quality with rigid and soft contact lenses. Eye Contact Lens 2012;38:171–178.